Cytek Biosciences Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
19 Sep 23 | SellUS$38,339,607 | RA Capital Management, L.P. | Company | 5,488,317 | US$7.15 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
State or Government | 26,825 | 0.0204% |
Private Companies | 36,286 | 0.0276% |
Individual Insiders | 11,567,956 | 8.81% |
VC/PE Firms | 13,466,434 | 10.3% |
General Public | 34,590,239 | 26.4% |
Institutions | 71,576,537 | 54.5% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
17,779,753 | US$110.2m | 6.02% | no data | |||
12,016,325 | US$74.5m | -11.4% | 0.87% | |||
11,890,700 | US$73.7m | 7.32% | no data | |||
6,809,404 | US$42.2m | 0% | 0.55% | |||
6,657,030 | US$41.3m | 0% | 0.23% | |||
5,988,502 | US$37.1m | -0.89% | no data | |||
5,684,615 | US$35.2m | 0% | 100.0% | |||
5,303,911 | US$32.9m | 0.3% | no data | |||
3,997,769 | US$24.8m | 5.83% | no data | |||
2,947,986 | US$18.3m | 25.6% | 0.02% | |||
2,456,535 | US$15.2m | 4.34% | no data | |||
1,291,258 | US$8.0m | -10.7% | no data | |||
1,190,624 | US$7.4m | 4.17% | no data | |||
1,064,333 | US$6.6m | 16.9% | no data | |||
880,038 | US$5.5m | 0% | no data | |||
774,682 | US$4.8m | -5.33% | no data | |||
573,600 | US$3.6m | 0% | no data | |||
527,140 | US$3.3m | 41.9% | no data | |||
524,713 | US$3.3m | 130% | 0.01% | |||
518,694 | US$3.2m | -5.76% | no data | |||
517,790 | US$3.2m | 0% | 1.28% | |||
353,318 | US$2.2m | -6.23% | no data | |||
327,630 | US$2.0m | 1.75% | no data | |||
314,580 | US$2.0m | 1.7% | no data | |||
307,583 | US$1.9m | 0% | no data |